体自组合与光动力疗法相遇:从分子设计到抗瘤应用
Shukun Li1,2, Jan C M van Hest2, Ruirui Xing1,3
1State Key Laboratory of Biopharmaceutical Preparation and Delivery, Institute of Process Engineering, Beijing 100190, China. rrxing@ipe.ac.cn.
概括
基于的光敏纳米药物为光动力疗法 (PDT) 提供可编程平台. 这些纳米药物增强光敏剂的传递, 克服关键的治疗障碍.
科学领域:
- 生物材料科学
- 纳米技术
- 癌症学
背景情况:
- 基于的光敏纳米药物代表了光动力疗法 (PDT) 的新平台.
- 这些纳米药物利用性质,如生物相容性和可编程性与光敏剂 (PS) 光活性.
- 它们可以精确控制PS的光物理性质和瘤输送.
研究的目的:
- 审查光敏剂 (PS) 纳米药物的设计和工程方面的最新进展.
- 专注于这些纳米药物的非共价相互作用,结构设计和功能整合.
- 讨论这些纳米药物在克服PDT的瘤传递障碍方面的潜力.
主要方法:
- 对PS纳米药物的当前文献的审查.
- 对超分子组装原理的分析.
- 讨论瘤传递的挑战和策略.
主要成果:
- -PS纳米药物显示出多功能性和可编程性的PDT.
- 超分子组装允许微调PS属性和目标传递.
- 这些纳米药物有望克服有效的PDT障碍.
结论:
- 基于的光敏纳米药物是PDT的一个有前途的纳米平台.
- 需要对设计,工程和临床翻译进行进一步的研究.
- 这些纳米药物有可能改善癌症治疗结果.
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


